Sterile Injectable Drugs Market - Global Industry Analysis

Sterile Injectable Drugs Market by Type (Small Molecules and Large Molecules), by Drug Class (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Vaccine, Immunoglobulin, Blood Factors, and Others), by Indication (Cardiology & Metabolic Disorders, Musculoskeletal, Neurology, Oncology, Autoimmune, Infectious Diseases, and Others), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and E-Commerce): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024

Published Date: 02-Jan-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3690 Status : Published

Global sterile injectable drugs market expected to generate around USD 779.9 billion by 2024, at a CAGR of around 11.25% between 2018 and 2024. The increasing preference for large molecule drugs over traditional drugs, rising incidences of chronic diseases fueling the global market.

Description

The report covers a forecast and an analysis of the sterile injectable drugs market on a global and regional level. The study provides historical data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the sterile injectable drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the sterile injectable drugs market on a global level.

In order to give the users of this report a comprehensive view of the sterile injectable drugs market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Sterile Injectable Drugs Market

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new service type launch, agreements, partnerships, collaborations & joint ventures, research & development, service type, and regional expansion of major participants involved in the market.

The study provides a decisive view of the sterile injectable drugs market by segmenting it based on type, drug class, indication, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Major players of the sterile injectable drugs market include GlaxoSmithKline PLC, Baxter International Inc., AstraZeneca, Johnson & Johnson Services, Inc., Sanofi, Merck & Co., Inc., Gilead Sciences Inc., Pfizer Inc., Novartis AG, and Nova Nordisk A/S, among others.

This report segments the global sterile injectable drugs market into:

Global Sterile Injectable Drugs Market: Type Analysis

  • Small Molecules
  • Large Molecules

Global Sterile Injectable Drugs Market: Drug Class Analysis

  • Monoclonal Antibodies
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Vaccine
  • Immunoglobulin
  • Blood Factors
  • Others 

Global Sterile Injectable Drugs Market: Indication Analysis

  • Cardiology and Metabolic Disorders
  • Musculoskeletal Disorders
  • Neurology Disorders
  • Autoimmune
  • Oncology
  • Infectious Diseases
  • Others

Global Sterile Injectable Drugs Market: Distribution Channel Analysis

  • Hospital Pharmacy
  • Retail Pharmacy
  • E-Commerce

Global Sterile Injectable Drugs Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global sterile injectable drugs market, 2015 - 2024 (USD Billion)
    • 2.2. Global sterile injectable drugs market: Snapshot
  •  
  • Chapter 3. Sterile Injectable Drugs Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global sterile injectable drugs market drivers: Impact analysis
      • 3.2.2. Rising focus on R&D for development of biotechnologically engineered anti-cancer drugs
      • 3.2.3. Need for immediate response in chronic disease cases raises growth
      • 3.2.4. Rapid growth in the usage of pre-filled syringes for biological products
    • 3.3. Market Restraints
      • 3.3.1. Global sterile injectable drugs market restraints: Impact analysis
      • 3.3.2. High operational costs and discontinuation of products
      • 3.3.3. Expensive operations and tall initial investments
    • 3.4. Opportunities
      • 3.4.1. Emerging Markets
    • 3.5. Porter's Five Forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by type
      • 3.6.2. Market attractiveness analysis, by drug class
      • 3.6.3. Market attractiveness analysis, by indication
      • 3.6.4. Market attractiveness analysis, by distribution channel
      • 3.6.5. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Sterile Injectable Drugs Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global sterile injectable drugs market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New material launch
      • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4. Research and development and regional expansion
  •  
  • Chapter 5. Global Sterile Injectable Drugs Market-Type Analysis
    • 5.1. Global sterile injectable drugs market: Type overview
      • 5.1.1. Global sterile injectable drugs market revenue share, by type, 2017 and 2024
    • 5.2. Small Molecule
      • 5.2.1. Global sterile injectable drugs market for small molecule, 2015 - 2024 (USD Billion)
    • 5.3. Large Molecule
      • 5.3.1. Global sterile injectable drugs market for large molecule,2015 - 2024 (USD Billion)
  •  
  • Chapter 6. Global Sterile Injectable Drugs Market- Drug Class Analysis
    • 6.1. Global sterile injectable drugs market: Drug Class overview
      • 6.1.1. Global sterile injectable drugs market revenue share, by drug class, 2017 and 2024
    • 6.2. Monoclonal Antibodies
      • 6.2.1. Global sterile injectable drugs market for monoclonal antibodies, 2015 - 2024 (USD Billion)
    • 6.3. Cytokines
      • 6.3.1. Global sterile injectable drugs market for cytokines,2015 - 2024 (USD Billion)
    • 6.4. Insulin
      • 6.4.1. Global sterile injectable drugs market for insulin, 2015 - 2024 (USD Billion)
    • 6.5. Peptide Hormones
      • 6.5.1. Global sterile injectable drugs market for peptide hormones, 2015 - 2024 (USD Billion)
    • 6.6. Vaccine
      • 6.6.1. Global sterile injectable drugs market for vaccine, 2015 - 2024 (USD Billion)
    • 6.7. Immunoglobulin
      • 6.7.1. Global sterile injectable drugs market for immunoglobulin, 2015 - 2024 (USD Billion)
    • 6.8. Blood Factors
      • 6.8.1. Global sterile injectable drugs market for blood factors, 2015 - 2024 (USD Billion)
    • 6.9. Others
      • 6.9.1. Global sterile injectable drugs market for others, 2015 - 2024 (USD Billion)
  •  
  • Chapter 7. Global Sterile Injectable Drugs Market - Indication Analysis
    • 7.1. Global sterile injectable drugs market: Indication overview
      • 7.1.1. Global sterile injectable drugs market revenue share, by indication, 2017 and 2024
    • 7.2. Cardiology & Metabolic Disorders
      • 7.2.1. Global sterile injectable drugs market for cardiology & metabolic disorders, 2015 - 2024 (USD Billion)
    • 7.3. Musculoskeletal Disorders
      • 7.3.1. Global sterile injectable drugs market for musculoskeletal disorders, 2015 - 2024 (USD Billion)
    • 7.4. Neurology
      • 7.4.1. Global sterile injectable drugs market for neurology, 2015 - 2024 (USD Billion)
    • 7.5. Oncology
      • 7.5.1. Global sterile injectable drugs market for oncology, 2015 - 2024 (USD Billion)
    • 7.6. Autoimmune
      • 7.6.1. Global sterile injectable drugs market for autoimmune, 2015 - 2024 (USD Billion)
    • 7.7. Infectious Diseases
      • 7.7.1. Global sterile injectable drugs market for infectious diseases, 2015 - 2024 (USD Billion)
    • 7.8. Others
      • 7.8.1. Global sterile injectable drugs market for others, 2015 - 2024 (USD Billion)
  •  
  • Chapter 8. Global Sterile Injectable Drugs Market - Distribution Channel Analysis
    • 8.1. Global sterile injectable drugs market: Distribution Channel overview
      • 8.1.1. Global sterile injectable drugs market revenue share, by distribution channel, 2017 and 2024
    • 8.2. Hospital Pharmacy
      • 8.2.1. Global sterile injectable drugs market for hospital pharmacy, 2015 - 2024 (USD Billion)
    • 8.3. Retail Pharmacy
      • 8.3.1. Global sterile injectable drugs market for retail pharmacy, 2015 - 2024 (USD Billion)
    • 8.4. E-Commerce
      • 8.4.1. Global sterile injectable drugs market for e-commerce, 2015 - 2024 (USD Billion)
  •  
  • Chapter 9. Global Sterile Injectable Drugs Market - Regional Analysis
    • 9.1. Global sterile injectable drugs market: Regional overview
      • 9.1.1. Global sterile injectable drugs market revenue share, by region, 2017 and 2024
    • 9.2. North America
      • 9.2.1. North America sterile injectable drugs market, 2015 - 2024 (USD Billion)
      • 9.2.2. North America sterile injectable drugs market revenue, by type, 2015 - 2024 (USD Billion)
      • 9.2.3. North America sterile injectable drugs market revenue, by drug class, 2015 - 2024 (USD Billion)
      • 9.2.4. North America sterile injectable drugs market revenue, by indication, 2015 - 2024 (USD Billion)
      • 9.2.5. North America sterile injectable drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 9.2.6. The U.S.
        • 9.2.6.1. The U.S. sterile injectable drugs market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.2.6.2. The U.S. sterile injectable drugs market revenue, by drug class, 2015 - 2024 (USD Billion)
        • 9.2.6.3. The U.S. sterile injectable drugs market revenue, by indication, 2015 - 2024 (USD Billion)
        • 9.2.6.4. The U.S. sterile injectable drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 9.2.7. Canada
        • 9.2.7.1. Canada sterile injectable drugs market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.2.7.2. Canada sterile injectable drugs market revenue, by liquid drug class, 2015 - 2024 (USD Billion)
        • 9.2.7.3. Canada sterile injectable drugs market revenue, by indication, 2015 - 2024 (USD Billion)
        • 9.2.7.4. Canada sterile injectable drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
    • 9.3. Europe
      • 9.3.1. Europe sterile injectable drugs market, 2015 - 2024 (USD Billion)
      • 9.3.2. Europe sterile injectable drugs market revenue, by type, 2015 - 2024 (USD Billion)
      • 9.3.3. Europe sterile injectable drugs market revenue, by drug class, 2015 - 2024 (USD Billion)
      • 9.3.4. Europe sterile injectable drugs market revenue, by indication, 2015 - 2024 (USD Billion)
      • 9.3.5. Europe sterile injectable drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 9.3.6. UK
        • 9.3.6.1. UK sterile injectable drugs market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.3.6.2. UK sterile injectable drugs market revenue, by drug class, 2015 - 2024 (USD Billion)
        • 9.3.6.3. UK sterile injectable drugs market revenue, by indication, 2015 - 2024 (USD Billion)
        • 9.3.6.4. UK sterile injectable drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 9.3.7. Germany
        • 9.3.7.1. Germany sterile injectable drugs market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.3.7.2. Germany sterile injectable drugs market revenue, by drug class, 2015 - 2024 (USD Billion)
        • 9.3.7.3. Germany sterile injectable drugs market revenue, by indication, 2015 - 2024 (USD Billion)
        • 9.3.7.4. Germany sterile injectable drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 9.3.8. France
        • 9.3.8.1. France sterile injectable drugs market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.3.8.2. France sterile injectable drugs market revenue, by drug class, 2015 - 2024 (USD Billion)
        • 9.3.8.3. France sterile injectable drugs market revenue, by indication, 2015 - 2024 (USD Billion)
        • 9.3.8.4. France sterile injectable drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 9.3.9. Rest of Europe
        • 9.3.9.1. Rest of Europe sterile injectable drugs market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.3.9.2. Rest of Europe sterile injectable drugs market revenue, by drug class, 2015 - 2024 (USD Billion)
        • 9.3.9.3. Rest of Europe sterile injectable drugs market revenue, by indication, 2015 - 2024 (USD Billion)
        • 9.3.9.4. Rest of Europe sterile injectable drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific sterile injectable drugs market, 2015 - 2024 (USD Billion)
      • 9.4.2. Asia Pacific sterile injectable drugs market revenue, by type, 2015 - 2024 (USD Billion)
      • 9.4.3. Asia Pacific sterile injectable drugs market revenue, by drug class, 2015 - 2024 (USD Billion)
      • 9.4.4. Asia Pacific sterile injectable drugs market revenue, by indication, 2015 - 2024 (USD Billion)
      • 9.4.5. Asia Pacific sterile injectable drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 9.4.6. China
        • 9.4.6.1. China sterile injectable drugs market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.4.6.2. China sterile injectable drugs market revenue, by drug class, 2015 - 2024 (USD Billion)
        • 9.4.6.3. China sterile injectable drugs market revenue, by indication, 2015 - 2024 (USD Billion)
        • 9.4.6.4. China sterile injectable drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 9.4.7. Japan
        • 9.4.7.1. Japan sterile injectable drugs market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.4.7.2. Japan sterile injectable drugs market revenue, by drug class, 2015 - 2024 (USD Billion)
        • 9.4.7.3. Japan sterile injectable drugs market revenue, by indication, 2015 - 2024 (USD Billion)
        • 9.4.7.4. Japan sterile injectable drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 9.4.8. India
        • 9.4.8.1. India sterile injectable drugs market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.4.8.2. India sterile injectable drugs market revenue, by drug class, 2015 - 2024 (USD Billion)
        • 9.4.8.3. India sterile injectable drugs market revenue, by indication, 2015 - 2024 (USD Billion)
        • 9.4.8.4. India sterile injectable drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 9.4.9. Rest of Asia Pacific
        • 9.4.9.1. Rest of Asia Pacific sterile injectable drugs market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.4.9.2. Rest of Asia Pacific sterile injectable drugs market revenue, by drug class, 2015 - 2024 (USD Billion)
        • 9.4.9.3. Rest of Asia Pacific sterile injectable drugs market revenue, by indication, 2015 - 2024 (USD Billion)
        • 9.4.9.4. Rest of Asia Pacific sterile injectable drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
    • 9.5. Latin America
      • 9.5.1. Latin America sterile injectable drugs market, 2015 - 2024 (USD Billion)
      • 9.5.2. Latin America sterile injectable drugs market revenue, by type, 2015 - 2024 (USD Billion)
      • 9.5.3. Latin America sterile injectable drugs market revenue, by drug class, 2015 - 2024 (USD Billion)
      • 9.5.4. Latin America sterile injectable drugs market revenue, by indication, 2015 - 2024 (USD Billion)
      • 9.5.5. Latin America sterile injectable drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 9.5.6. Brazil
        • 9.5.6.1. Brazil sterile injectable drugs market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.5.6.2. Brazil sterile injectable drugs market revenue, by drug class, 2015 - 2024 (USD Billion)
        • 9.5.6.3. Brazil sterile injectable drugs market revenue, by indication, 2015 - 2024 (USD Billion)
        • 9.5.6.4. Brazil sterile injectable drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
      • 9.5.7. Rest of Latin America
        • 9.5.7.1. Rest of Latin America sterile injectable drugs market revenue, by type, 2015 - 2024 (USD Billion)
        • 9.5.7.2. Rest of Latin America sterile injectable drugs market revenue, by drug class, 2015 - 2024 (USD Billion)
        • 9.5.7.3. Rest of Latin America sterile injectable drugs market revenue, by indication, 2015 - 2024 (USD Billion)
        • 9.5.7.4. Rest of Latin America sterile injectable drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
    • 9.6. The Middle East and Africa
      • 9.6.1. The Middle East and Africa sterile injectable drugs market, 2015 - 2024 (USD Billion)
      • 9.6.2. The Middle East and Africa sterile injectable drugs market revenue, by type, 2015 - 2024 (USD Billion)
      • 9.6.3. The Middle East and Africa sterile injectable drugs market revenue, by drug class, 2015 - 2024 (USD Billion)
      • 9.6.4. The Middle East and Africa sterile injectable drugs market revenue, by indication, 2015 - 2024 (USD Billion)
      • 9.6.5. The Middle East and Africa sterile injectable drugs market revenue, by distribution channel, 2015 - 2024 (USD Billion)
  •  
  • Chapter 10. Company Profile
    • 10.1. Baxter International Inc.
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Product Portfolio
      • 10.1.4. Business Strategy
      • 10.1.5. Recent Developments
    • 10.2. Sanofi
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Product Portfolio
      • 10.2.4. Business Strategy
      • 10.2.5. Recent Developments
    • 10.3. Pfizer Inc.
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Product Portfolio
      • 10.3.4. Business Strategy
      • 10.3.5. Recent Developments
    • 10.4. GlaxoSmithKline PLC
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Product Portfolio
      • 10.4.4. Business Strategy
      • 10.4.5. Recent Developments
    • 10.5. AstraZeneca
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Product Portfolio
      • 10.5.4. Business Strategy
      • 10.5.5. Recent Developments
    • 10.6. Gilead Sciences Inc.
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Product Portfolio
      • 10.6.4. Business Strategy
      • 10.6.5. Recent Developments
    • 10.7. Merck & Co., Inc.
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Product Portfolio
      • 10.7.4. Business Strategy
      • 10.7.5. Recent Developments
    • 10.8. Novartis AG
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Product Portfolio
      • 10.8.4. Business Strategy
      • 10.8.5. Recent Developments
    • 10.9. Johnson & Johnson Services, Inc.
      • 10.9.1. Overview
      • 10.9.2. Financials
      • 10.9.3. Product Portfolio
      • 10.9.4. Business Strategy
      • 10.9.5. Recent Developments
    • 10.10. Nova Nordisk A/S
      • 10.10.1. Overview
      • 10.10.2. Financials
      • 10.10.3. Product Portfolio
      • 10.10.4. Business Strategy
      • 10.10.5. Recent Developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global sterile injectable drugs market revenue, 2015 – 2024 (USD Billion) 
4. Porter’s Five Forces Analysis
5. Sterile Injectable Drugs market attractiveness analysis, by type 
6. Sterile Injectable Drugs market attractiveness analysis, by drug class 
7. Sterile Injectable Drugs market attractiveness analysis, by indication 
8. Sterile Injectable Drugs market attractiveness analysis, by distribution channel
9. Sterile Injectable Drugs market: market attractiveness analysis, by region 
10. Company market share analysis, 2017 
11. Global sterile injectable drugs market revenue share, by type, 2017 and 2024
12. Global sterile injectable drugs market for small molecule, 2015 – 2024 (USD Billion)
13. Global sterile injectable drugs market for large molecule, 2015 – 2024 (USD Billion)
14. Global sterile injectable drugs market revenue share by, drug class, 2017 and 2024
15. Global sterile injectable drugs market for monoclonal antibodies, 2015 – 2024 (USD Billion)
16. Global sterile injectable drugs market for cytokines, 2015 – 2024 (USD Billion)
17. Global sterile injectable drugs market for insulin, 2015 – 2024 (USD Billion)
18. Global sterile injectable drugs market for peptide hormones, 2015 – 2024 (USD Billion)
19. Global sterile injectable drugs market for vaccine, 2015 – 2024 (USD Billion)
20. Global sterile injectable drugs market for immunoglobulin, 2015 – 2024 (USD Billion)
21. Global sterile injectable drugs market for blood factors, 2015 – 2024 (USD Billion)
22. Global sterile injectable drugs market for others, 2015 – 2024 (USD Billion)
23. Global sterile injectable drugs market revenue share by indication, 2017 and 2024
24. Global sterile injectable drugs market for cardiology & metabolic disorders, 2015 – 2024 (USD Billion)
25. Global sterile injectable drugs market for musculoskeletal disorders, 2015 – 2024 (USD Billion)
26. Global sterile injectable drugs market for neurology, 2015 – 2024 (USD Billion)
27. Global sterile injectable drugs market for oncology, 2015 – 2024 (USD Billion)
28. Global sterile injectable drugs market for autoimmune, 2015 – 2024 (USD Billion)
29. Global sterile injectable drugs market for infectious diseases, 2015 – 2024 (USD Billion)
30. Global sterile injectable drugs market for others, 2015 – 2024 (USD Billion)
31. Global sterile injectable drugs market revenue share by distribution channel, 2017 and 2024
32. Global sterile injectable drugs market for hospital pharmacy, 2015 – 2024 (USD Billion)
33. Global sterile injectable drugs market for retail pharmacy, 2015 – 2024 (USD Billion)
34. Global sterile injectable drugs market for e-commerce, 2015 – 2024 (USD Billion)
35. North America sterile injectable drugs market, 2015-2024 (USD Billion)
36. Europe sterile injectable drugs market, 2015-2024 (USD Billion)
37. Asia Pacific sterile injectable drugs market, 2015-2024 (USD Billion)
38. Latin America sterile injectable drugs market, 2015-2024 (USD Billion)
39. The Middle East and Africa sterile injectable drugs market, 2015-2024(USD Billion)


Table Of Tables

List of Tables

1. Global sterile injectable drugs market: Market Snapshot                                                                                                             
2. Drivers of global sterile injectable drugs market: Impact analysis 
3. Restraints of global sterile injectable drugs market: Impact analysis  
4. North America sterile injectable drugs market revenue, by type, 2015 – 2024 (USD Billion)
5. North America sterile injectable drugs market revenue, by drug class, 2015 – 2024 (USD Billion)
6. North America sterile injectable drugs market revenue, by indication, 2015 – 2024 (USD Billion)
7. North America sterile injectable drugs market revenue, by distribution channel, 2015 – 2024 (USD Billion)
8. The U.S. sterile injectable drugs market revenue, by type, 2015 – 2024 (USD Billion)
9. The U.S. sterile injectable drugs market revenue, by drug class, 2015 – 2024 (USD Billion)
10. The U.S. sterile injectable drugs market revenue, by indication, 2015 – 2024 (USD Billion)
11. The U.S. sterile injectable drugs market revenue, by distribution channel, 2015 – 2024 (USD Billion)
12. Canada sterile injectable drugs market revenue, by type, 2015 – 2024 (USD Billion)
13. Canada sterile injectable drugs market revenue, by drug class, 2015 – 2024 (USD Billion)
14. Canada sterile injectable drugs market revenue, by indication, 2015 – 2024 (USD Billion)
15. Canada sterile injectable drugs market revenue, by distribution channel, 2015 – 2024 (USD Billion)
16. Europe sterile injectable drugs market revenue, by type, 2015 – 2024 (USD Billion)
17. Europe sterile injectable drugs market revenue, by drug class, 2015 – 2024 (USD Billion)
18. Europe sterile injectable drugs market revenue, by indication, 2015 – 2024 (USD Billion)
19. Europe sterile injectable drugs market revenue, by distribution channel, 2015 – 2024 (USD Billion)
20. UK sterile injectable drugs market revenue, by type, 2015 – 2024 (USD Billion)
21. UK sterile injectable drugs market revenue, by drug class, 2015 – 2024 (USD Billion)
22. UK sterile injectable drugs market revenue, by indication, 2015 – 2024 (USD Billion)
23. UK sterile injectable drugs market revenue, by distribution channel, 2015 – 2024 (USD Billion)
24. Germany sterile injectable drugs market revenue, by type, 2015 – 2024 (USD Billion)
25. Germany sterile injectable drugs market revenue, by drug class, 2015 – 2024 (USD Billion)
26. Germany sterile injectable drugs market revenue, by indication, 2015 – 2024 (USD Billion)
27. Germany sterile injectable drugs market revenue, by distribution channel, 2015 – 2024 (USD Billion)
28. France sterile injectable drugs market revenue, by type, 2015 – 2024 (USD Billion)
29. France sterile injectable drugs market revenue, by drug class, 2015 – 2024 (USD Billion)
30. France sterile injectable drugs market revenue, by indication, 2015 – 2024 (USD Billion)
31. France sterile injectable drugs market revenue, by distribution channel, 2015 – 2024 (USD Billion)
32. Rest of Europe sterile injectable drugs market revenue, by type, 2015 – 2024 (USD Billion)
33. Rest of Europe sterile injectable drugs market revenue, by drug class, 2015 – 2024 (USD Billion)
34. Rest of Europe sterile injectable drugs market revenue, by indication, 2015 – 2024 (USD Billion)
35. Rest of Europe sterile injectable drugs market revenue, by distribution channel, 2015 – 2024 (USD Billion)
36. Asia Pacific sterile injectable drugs market revenue, by type, 2015 – 2024 (USD Billion)
37. Asia Pacific sterile injectable drugs market revenue, by drug class, 2015 – 2024 (USD Billion)
38. Asia Pacific sterile injectable drugs market revenue, by indication, 2015 – 2024 (USD Billion)
39. Asia Pacific sterile injectable drugs market revenue, by distribution channel, 2015 – 2024 (USD Billion)
40. China sterile injectable drugs market revenue, by type, 2015 – 2024 (USD Billion)
41. China sterile injectable drugs market revenue, by drug class, 2015 – 2024 (USD Billion)
42. China sterile injectable drugs market revenue, by indication, 2015 – 2024 (USD Billion)
43. China sterile injectable drugs market revenue, by distribution channel, 2015 – 2024 (USD Billion)
44. Japan sterile injectable drugs market revenue, by type, 2015 – 2024 (USD Billion)
45. Japan sterile injectable drugs market revenue, by drug class, 2015 – 2024 (USD Billion)
46. Japan sterile injectable drugs market revenue, by indication, 2015 – 2024 (USD Billion)
47. Japan sterile injectable drugs market revenue, by distribution channel, 2015 – 2024 (USD Billion)
48. India sterile injectable drugs market revenue, by type, 2015 – 2024 (USD Billion)
49. India sterile injectable drugs market revenue, by drug class, 2015 – 2024 (USD Billion)
50. India sterile injectable drugs market revenue, by indication, 2015 – 2024 (USD Billion)
51. India sterile injectable drugs market revenue, by distribution channel, 2015 – 2024 (USD Billion)
52. Rest of Asia Pacific sterile injectable drugs market revenue, by type, 2015 – 2024 (USD Billion)
53. Rest of Asia Pacific sterile injectable drugs market revenue, by drug class, 2015 – 2024 (USD Billion)
54. Rest of Asia Pacific sterile injectable drugs market revenue, by indication, 2015 – 2024 (USD Billion)
55. Rest of Asia Pacific sterile injectable drugs market revenue, by distribution channel, 2015 – 2024 (USD Billion)
56. Latin America sterile injectable drugs market revenue, by type, 2015 – 2024 (USD Billion)
57. Latin America sterile injectable drugs market revenue, by drug class, 2015 – 2024 (USD Billion)
58. Latin America sterile injectable drugs market revenue, by indication, 2015 – 2024 (USD Billion)
59. Latin America sterile injectable drugs market revenue, by distribution channel, 2015 – 2024 (USD Billion)
60. Brazil sterile injectable drugs market revenue, by type, 2015 – 2024 (USD Billion)
61. Brazil sterile injectable drugs market revenue, by drug class, 2015 – 2024 (USD Billion)
62. Brazil sterile injectable drugs market revenue, by indication, 2015 – 2024 (USD Billion)
63. Brazil sterile injectable drugs market revenue, by distribution channel, 2015 – 2024 (USD Billion)
64. Rest of Latin America sterile injectable drugs market revenue, by type, 2015 – 2024 (USD Billion)
65. Rest of Latin America sterile injectable drugs market revenue, by drug class, 2015 – 2024 (USD Billion)
66. Rest of Latin America sterile injectable drugs market revenue, by indication, 2015 – 2024 (USD Billion)
67. Rest of Latin America sterile injectable drugs market revenue, by distribution channel, 2015 – 2024 (USD Billion)
68. The Middle East and Africa sterile injectable drugs market revenue, by type, 2015 – 2024 (USD Billion)
69. The Middle East and Africa sterile injectable drugs market revenue, by drug class, 2015 – 2024 (USD Billion)
70. The Middle East and Africa sterile injectable drugs market revenue, by indication, 2015 – 2024 (USD Billion)
71. The Middle East and Africa sterile injectable drugs market revenue, by distribution channel, 2015 – 2024 (USD Billion)

Methodology

Free Analysis

Sterile injectable drugs are given intravenously to patients. These drugs are generally free from other types of bacteria and are consumed via syringes or saline. Large and small molecules are the two types of sterile injectable drugs available in the market.

The increasing preference for large molecule drugs over traditional drugs, rising cases of chronic diseases, and the requirement of large molecules for the treatment of chronic diseases are major growth factors likely to fuel the sterile injectable drugs market in the future. The rise in the use of biologics, monoclonal antibodies, and antibody-drugs conjugate to treat various diseases is also anticipated to boost the development of the sterile injectable drugs market globally in the estimated time period. The rapid changes in the regulations for manufacturing sterile injectable drugs by FDA are also estimated to contribute toward the market for sterile injectable drugs. However, the high investment and operational costs might hinder the development of the sterile injectable drugs market on a global scale.

Global Sterile Injectable Drugs Market

The global market for sterile injectable drugs is divided based on type, indication, drug class, and distribution channel. By type, the market is classified into large molecules and small molecules. Large molecules are anticipated to dominate the sterile injectable drugs market. The indication segment comprises musculoskeletal disorders, neurology, oncology, autoimmune, contagious diseases, cardiology and metabolic disorders, and others. Oncology is expected to dominate the sterile injectable drugs market globally. By drug class, the sterile injectable drugs market includes insulin, vaccine, peptide hormones, monoclonal antibodies, immunoglobulin, cytokines, blood factors, and others. Monoclonal antibodies are likely to lead this global market. By distribution channel, the market includes hospital pharmacy, retail pharmacy, and e-commerce.

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa comprise the regional segment of the global sterile injectable drugs market. North America is projected to lead the market for sterile injectable drugs in the forecast time period, due to the rapid developments made in healthcare infrastructure, the presence of major players in the region, and huge investments made in the research and development. The Asia Pacific is predicted to register the highest rate of growth in the sterile injectable drugs market, owing to the presence of a large patient pool, the presence of various small pharma companies in India and China, the introduction of different types of policies by various government bodies, and rising awareness about sterile injectable drugs.

Major players of the sterile injectable drugs market include GlaxoSmithKline PLC, Baxter International Inc., AstraZeneca, Johnson & Johnson Services, Inc., Sanofi, Merck & Co., Inc., Gilead Sciences Inc., Pfizer Inc., Novartis AG, and Nova Nordisk A/S, among others.

Choose License Type

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed